PNPLA3 and TM6SF2 were the most common NASH-associated polymorphisms, and patients with TM6SF2 showed a significant reduction in GGT and ALT with the administration of UDCA. Here, PNPLA3 is linked to metabolic dysfunction-associated steatohepatitis.